Fongit is a startup incubator and accelerator located in Geneva, Switzerland, established in 1991. The organization focuses on supporting high-tech ventures, including startups, scale-ups, and small to medium-sized enterprises (SMEs) that are experiencing rapid growth. Fongit collaborates with local research institutions, universities, and higher education establishments to foster innovation, particularly in the fields of information and communications technology (ICT), engineering, and life sciences. The incubator is committed to advancing technological innovations that align with Sustainable Development Goals, thereby promoting a sustainable future through entrepreneurial efforts.
BrainScape Medical is a Swiss life sciences startup focused on developing an end-to-end solution for brain disorder management and care, addressing many limitations of current approaches.
AnimalCare Engineering
Grant in 2025
AnimalCare Engineering dedicated to enhancing the quality of life for pets through innovative health monitoring technology. Its cutting-edge devices empower pet owners and veterinarians with real-time insights, ensuring the best possible care.
EarlySight
Debt Financing in 2025
EarlySight SA is a Swiss company, established in 2016 and based in Lausanne, that focuses on developing innovative medical devices for the early detection and treatment of eye diseases. The company has created an advanced eye fundus camera that enhances retinal imaging through precise illumination and real-time correction of ocular aberrations. This device utilizes cellular-level imaging technology to identify subtle structural changes in the retina, allowing for effective monitoring of treatment outcomes in a quick and non-invasive manner. By facilitating the visualization of cell morphology within the retina, EarlySight aims to improve the capabilities of eye specialists in diagnosing and managing ocular conditions.
FlowRide
Grant in 2025
FlowRide provides a more fluid and efficient transportation alternative.
Immitra Bio
Debt Financing in 2025
Immitra Bio is a biotechnology company developing a proprietary genetic medicine platform that combines hematopoietic stem cells and CRISPR-Cas9 gene editing. This innovative approach enables precise, long-lasting gene alterations within blood stem cells, offering transformative treatments for rare diseases with significant unmet medical needs, particularly inherited blood disorders.
Miloo
Debt Financing in 2025
Miloo is a Swiss electric mobility company that specializes in high-performance electric bikes designed for urban transportation. The company focuses on creating stylish and powerful e-bikes that enhance the commuting experience by offering greater range, comfort, and freedom. Assembled in Switzerland, Miloo's vehicles adhere to rigorous safety and performance standards, making them suitable for navigating city environments. The e-bikes are equipped with advanced engineering and digital tools, providing riders with a connected and enjoyable means of travel. Miloo aims to redefine urban mobility by offering a sustainable alternative to traditional transport options, allowing users to bypass traffic and crowded public transport while promoting clean and agile two-wheel mobility.
Adoram Therapeutics
Pre Seed Round in 2025
Adoram Therapeutics is a biopharmaceutical company focused on developing innovative therapies for patients with immune-based diseases and solid tumors. The company specializes in allosteric modulators, which are designed to enhance the effectiveness of cancer immunotherapy by targeting specific mechanisms within the immune system. By leveraging small molecule immunotherapy, Adoram aims to overcome the limitations of earlier drug generations, particularly in adenosine-rich tumors. This approach allows researchers to address significant unmet medical needs in onco-immunology, ultimately striving to improve treatment outcomes for patients suffering from these challenging conditions.
Cerret
Funding Round in 2025
Cerret, a Swiss-based jewelry brand, specializes in designing and manufacturing smart bracelets for women's safety. Their products, equipped with advanced technology, allow users to discreetly alert loved ones or authorities in case of an emergency, providing a sense of security and peace of mind.
Effetto Venturi
Debt Financing in 2024
Effetto Venturi specializes in the production of autonomous, lightweight buoys. These buoys, equipped with electric thrusters and remote control capabilities, can maintain precise positions in water without the need for anchoring. They are designed for various applications, including temporary water separation, event management, and water monitoring in ports.
The ShowCase
Debt Financing in 2024
The ShowCase offers revolutionary portable studio system for exhibiting luxury products.
Astrocyte
Debt Financing in 2024
Astrocyte is a brain-penetrant inhibitor to improve memory function.
Dyneo Technologies
Debt Financing in 2024
Dyneo Technologies specializes in data-driven solutions for the district heating and cooling industry. The company offers a Software as a Service (SaaS) platform that empowers operators to boost energy efficiency and increase renewable energy integration. Dyneo's technology identifies and addresses performance-degrading issues at scale, while its optimization tools autonomously enhance the profitability and sustainability of thermal networks.
Adoram Therapeutics
Debt Financing in 2024
Adoram Therapeutics is a biopharmaceutical company focused on developing innovative therapies for patients with immune-based diseases and solid tumors. The company specializes in allosteric modulators, which are designed to enhance the effectiveness of cancer immunotherapy by targeting specific mechanisms within the immune system. By leveraging small molecule immunotherapy, Adoram aims to overcome the limitations of earlier drug generations, particularly in adenosine-rich tumors. This approach allows researchers to address significant unmet medical needs in onco-immunology, ultimately striving to improve treatment outcomes for patients suffering from these challenging conditions.
Alpes-éco
Debt Financing in 2024
Alpes-éco Suisse specializes in developing smart herd management solutions for farmers. Their primary product is livestock management software, which optimizes daily animal care, including milk production control and health evaluation. The company's connected devices, accessible via smartphones, enable efficient management of livestock, even in remote areas, thereby enhancing sustainability and efficiency in the agricultural sector.
Neurovia Bioelectronics
Grant in 2024
Neurovia Bioelectronics is revolutionizing blood pressure management by offering innovative solutions to improve health outcomes and quality of life. It utilizes established microfabrication technologies and 3D manufacturing techniques to create endovascular stimulation devices
Wyss Center
Debt Financing in 2024
Epios personalized and precision management of brain disorders using daily life monitoring and therapeutics. The Epios system comprises a series of thin leads incorporating sensing electrodes and a miniature implant, inserted beneath the skin. The neural signals are wirelessly transmitted to an external receiver held in place on the skin directly over the implant with a magnet, and from there are conveyed to a wearable data processor and are finally securely stored in the Epios Cloud.
HekeTiss
Debt Financing in 2024
HekeTiss SA, a spin-off from the University Hospitals of Geneva and the University of Geneva, specializes in the manufacture of medical and dental instruments. The company has developed an innovative product called TrophiPatch, a cellular patch that mimics real skin and is engineered from stem cells derived from human adipose tissue. This advanced patch actively secretes factors that enhance the wound healing process, aiming to restore blood vessels in wounds. HekeTiss's TrophiPatch is designed to facilitate effective and cost-efficient treatment for chronic ulcers, significantly reducing the time required for healing.
Azure Cell Therapies
Grant in 2024
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
Firefly Fusion
Grant in 2024
Firefly Fusion is a pioneering company specializing in the development of standard tokamaks, a type of device that facilitates nuclear fusion. Their mission is to generate clean and sustainable energy through controlled nuclear reactions, harnessing the power of fusion. The company employs microwaves to create and control hot plasma, aiming to complement renewable energy sources. By utilizing proven technologies and cutting-edge science, Firefly Fusion seeks to enable organizations, governments, and industries to transition towards sustainable energy.
Antion Biosciences
Debt Financing in 2024
Antion Biosciences SA is a biotechnology company based in Geneva, Switzerland, focused on cell and gene engineering. The company develops off-the-shelf therapies aimed at treating diseases that have significant unmet medical needs, particularly in the realm of autoimmune diseases. Antion utilizes proprietary technology to create multiplexed gene-modified cell therapies, enabling a modular and tunable approach to therapeutic cell engineering. This innovative method not only enhances clinical safety and efficacy but also aims to ensure broad accessibility of treatments, even in resource-poor communities. Recently, Antion has shifted its focus to repurpose its miCAR19 developments for autoimmune conditions, building on promising preclinical proof-of-concept data from its lead product, miCAR7. The company is positioned as one of the few in the field offering an allogeneic solution, with significant progress made towards achieving proof-of-concept in human trials.
nsave
Seed Round in 2024
Nsave is a fintech startup focused on providing a digital banking services platform designed to offer secure savings solutions. The platform allows customers to save in multiple currencies, including USD, EUR, and GBP, while ensuring the highest level of financial security. Nsave promotes financial inclusion by removing account restrictions, enabling users to access global safe accounts for their funds. This approach aims to enhance the financial well-being of individuals by making saving more accessible and secure.
HeroSupport
Seed Round in 2024
HeroSupport is a medical device manufacturing company based in Veyrier, Geneva, established in 2019. The company specializes in creating personalized solutions that transform imaging and treatment tables into medical immobilization devices designed to enhance patient comfort during clinical procedures. By providing tailored support, these devices allow patients to receive prone breast radiotherapy without the need to adapt to the standard table setup. This innovation not only improves patient comfort but also aims to enhance the effectiveness and cost efficiency of cancer treatment for healthcare providers.
Transmutex
Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
Carrat Sàrl
Seed Round in 2023
Carrat Sàrl is a company that makes bracelets that send an emergency call with the press of a button.
MPC Therapeutics
Debt Financing in 2023
MPC Therapeutics is a biotechnology company focused on developing innovative therapies for cancer and degenerative disorders. The company is dedicated to creating life-altering medications by utilizing its expertise in medicinal chemistry and mitochondrial biology. MPC Therapeutics is specifically working on mitochondrial pyruvate carrier inhibitor compounds aimed at enhancing the effectiveness of T-cell therapies. These compounds have the potential to alter mitochondrial processes, improving cellular conductivity and inhibiting disease progression. By targeting metabolic and neurodegenerative diseases, MPC Therapeutics aims to provide new treatment options within the medical industry.
EarlySight
Debt Financing in 2023
EarlySight SA is a Swiss company, established in 2016 and based in Lausanne, that focuses on developing innovative medical devices for the early detection and treatment of eye diseases. The company has created an advanced eye fundus camera that enhances retinal imaging through precise illumination and real-time correction of ocular aberrations. This device utilizes cellular-level imaging technology to identify subtle structural changes in the retina, allowing for effective monitoring of treatment outcomes in a quick and non-invasive manner. By facilitating the visualization of cell morphology within the retina, EarlySight aims to improve the capabilities of eye specialists in diagnosing and managing ocular conditions.
KYLYS
Debt Financing in 2023
KYLYS is a Swiss company based in Geneva, founded in March 2017, specializing in the development of biomolecule-based products for medical, surgical, and cosmetic applications. The company offers innovative hyaluronic acid pearls, which are biocompatible and biodegradable gels designed for easy injection at room temperature. These gels form microgel structures at body temperature, providing a durable effect without migrating from the injection site. This enables healthcare providers to deliver effective and safe products to their patients, addressing a range of medical and cosmetic needs.
FluoSphera
Debt Financing in 2023
FluoSphera is a company focused on the development of innovative drugs that minimize adverse side effects and reduce reliance on animal testing. By addressing the complexities of human physiological responses, FluoSphera aims to assist organizations in creating safer pharmaceuticals and protecting populations from harmful compounds. Their approach emphasizes efficiency in drug discovery, ultimately enhancing public health and safety.
Consulto
Grant in 2023
Consulto intends to change the way outpatient care is delivered by extending team-based care beyond hospital walls.
Plair SA
Debt Financing in 2023
Plair SA specializes in the development and manufacturing of advanced systems for monitoring environmental conditions, particularly focusing on airborne particles. Founded in 2014 and based in Geneva, Switzerland, the company offers a range of innovative instruments, including the Particle Analyzer PA-300, which provides real-time detection, identification, and classification of fine particles in the air. This device can differentiate various entities such as pollen species, organic particles like fungal spores, and pollutants including polycyclic aromatic hydrocarbons. Additionally, Plair SA's Rapid-E and Rapid-C instruments utilize cutting-edge technologies like laser-induced fluorescence and light scattering for comprehensive analysis of aerosol particles. The company's solutions cater to applications in airborne allergen monitoring, air quality assessment, and bioaerosol analysis, enabling a deeper understanding of atmospheric aerosol concentrations. Plair SA is a spin-off from the University of Geneva, reflecting its strong academic foundation.
Endotelix
Debt Financing in 2023
Endotelix is a Swiss biotech start-up and a spin-off from the University of Geneva, focused on developing innovative solutions for Antiphospholipid Syndrome. The company specializes in creating fast, sensitive, and reliable diagnostic tests and treatment options aimed at detecting circulating antibodies associated with this condition. Endotelix primarily targets the healthcare needs of pregnant women and adolescent children, providing research tools and therapies that assist healthcare professionals in reducing pregnancy-related complications and enhancing overall healthcare outcomes.
Ovomind
Seed Round in 2022
Ovomind is focused on transforming the gaming experience by integrating emotional interaction through innovative technology. The company has developed smart emotion computing wristbands that utilize sensors to detect players' emotional states from biosignals. This data is processed in real-time via a cloud-based algorithm, allowing game developers to adapt gameplay and streaming experiences based on the user's emotions. By centering on the human experience, Ovomind aims to create a new generation of user experience that enhances engagement and interactivity in video games. This approach seeks to redefine how players connect with games and with each other, fostering a more immersive and emotionally resonant gaming environment.
Terapet
Debt Financing in 2022
Terapet SA, founded in 2019 in Geneva, Switzerland, specializes in proton therapy, an advanced form of radiotherapy for cancer treatment. Established by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals, the company aims to provide precise tumor targeting while minimizing damage to adjacent healthy tissues. Terapet's innovative technology allows for a reduced radiation dose to surrounding healthy cells by administering high doses of protons that halt at specific depths within the patient. This capability enables medical professionals to monitor the proton dose in real-time and in three dimensions, making cancer treatment more effective and potentially more cost-efficient. The company has successfully demonstrated the feasibility of its concept and is in the process of developing an initial version for market launch.
EBAMed
Debt Financing in 2022
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.
iOnctura
Debt Financing in 2022
iOnctura is a biopharmaceutical company that develops novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which can hinder effective cancer treatment. The company focuses on creating next-generation biomolecules to enhance existing immune checkpoint therapies, ultimately aiming to improve patient outcomes in cancer treatment. Through collaborations with Merck and Cancer Research Technology, iOnctura is advancing a pipeline of preclinical molecules designed to be used in combination with immuno-oncology therapies. With access to state-of-the-art drug discovery laboratories and a network of academic partners, iOnctura is strategically positioned to develop innovative combination therapies in cancer immunology, ensuring a focused approach to tackling the complexities of cancer and fibrosis.
V-Labs
Debt Financing in 2022
V-Labs specializes in augmented reality technology tailored for excavation operations. The company has developed a system that allows users to visualize complex geospatial data directly at the worksite with centimeter-level accuracy. This technology includes a local positioning system that aids operators and contractors in minimizing damage to underground infrastructure while enhancing the efficiency of excavation processes. By integrating augmented reality into excavation tasks, V-Labs aims to improve safety and streamline workflows in the construction industry.
Deasyl
Debt Financing in 2022
Deasyl specializes in the development of innovative, eco-friendly chemical solutions aimed at transforming traditional chemical processes. The company focuses on creating scalable methods that are utilized by major players in the fine chemical and petrochemical industries. By advancing clean technology, Deasyl promotes sustainable practices through waste valorization and the conversion of biomass into renewable products. Their work encompasses recycling processes and the production of biodiesel, allowing clients to adopt greener technologies and contribute to environmental sustainability.
GliaPharm
Debt Financing in 2022
GliaPharm SA is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders. Founded in 2016 and based in Geneva, the company utilizes its GliaX technology platform to identify drugs that target the activity of glial cells, which are essential support cells for neurons. This innovative approach aims to enhance brain metabolism in pathological conditions. GliaPharm employs high throughput screening technologies and conducts metabolic tests on both in vitro primary brain cell cultures and in vivo rodent models to evaluate compounds. The company addresses various neurological conditions, including Alzheimer's disease and amyotrophic lateral sclerosis (ALS), and collaborates with contract research organizations to advance its drug development and regulatory processes. With a vision to lead in glia-mediated therapies, GliaPharm seeks to provide new neuroprotective agents that support cognitive function in patients.
Transmutex
Debt Financing in 2022
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
Impaakt
Debt Financing in 2022
Impaakt SA operates a collaborative platform that utilizes collective intelligence to generate research and evaluations of the social and environmental impacts of companies. Established in 2017 and headquartered in Carouge, Switzerland, the company offers standardized impact reports on individual enterprises, sectors, and Sustainable Development Goals (SDGs). Its platform also includes data analytics tools and impact scores, enabling asset managers to incorporate impact analysis into their investment strategies effectively. By providing accurate and comprehensive assessments, Impaakt aims to support informed decision-making in the realm of sustainable investment.
Diabeto
Grant in 2022
Diabeto is a biopharmaceutical start-up project spinning off the University of Geneva and based on pioneering expertise in discovery of mechanisms sustaining life without insulin.
ORamaVR
Debt Financing in 2022
ORamaVR is focused on transforming medical training through immersive virtual reality (VR) solutions. The company offers an IT platform, MAGES-SDK, that enables medical organizations to create high-fidelity VR simulations at a fraction of the cost and time compared to traditional methods. These simulations are utilized by hospitals, medical schools, and training centers to educate and evaluate medical professionals. The effectiveness of this platform is supported by nine clinical trials and over fifty scientific publications. ORamaVR has gained recognition from numerous prestigious institutions worldwide, including universities and healthcare organizations in the United States and Europe. The company has received several international awards for its societal impact and has established partnerships with notable organizations such as Airbus and Microsoft. Additionally, ORamaVR has secured venture capital funding from various strategic investors, including HTC Vive, further solidifying its position in the medical VR landscape.
Adiposs
Seed Round in 2021
Adiposs SA is a clinical-stage life science company focused on developing innovative medical imaging products aimed at the early detection of cachexia, a serious condition characterized by severe body wasting. The company has created a first-in-class CT contrast product that allows for the detection of body wasting prior to noticeable weight loss, potentially up to a year earlier. This advancement enables healthcare providers to identify cancer at an earlier stage, ultimately improving patient outcomes and enhancing their quality of life. By facilitating timely intervention, Adiposs aims to provide patients with a better chance of survival against cancer and other chronic illnesses.
HekeTiss
Grant in 2021
HekeTiss SA, a spin-off from the University Hospitals of Geneva and the University of Geneva, specializes in the manufacture of medical and dental instruments. The company has developed an innovative product called TrophiPatch, a cellular patch that mimics real skin and is engineered from stem cells derived from human adipose tissue. This advanced patch actively secretes factors that enhance the wound healing process, aiming to restore blood vessels in wounds. HekeTiss's TrophiPatch is designed to facilitate effective and cost-efficient treatment for chronic ulcers, significantly reducing the time required for healing.
ABCDx
Convertible Note in 2021
ABCDx SA is a Swiss company founded in 2014 that specializes in the development, validation, and application of biomarker tests for brain injury treatment. The company focuses on creating biomarker panels designed to identify and diagnose patients at risk for severe long-term complications resulting from conditions such as traumatic brain injuries, strokes, and post-stroke infections. The founders are prominent researchers from the University of Geneva and the Vall d’Hebron Research Institute, bringing significant expertise in biomarker discovery and clinical application. They are complemented by a third founder with extensive experience in the diagnostic and pharmaceutical industries, enhancing the company’s capacity to innovate in brain health diagnostics.
Neurosoft Bioelectronics
Convertible Note in 2021
Neurosoft Bioelectronics specializes in the development of soft implantable electrodes designed to interface with the nervous system for diagnosing and treating neurological disorders. Based in Geneva, Switzerland, the company has created next-generation electrodes that are compliant and conformable, addressing the limitations of existing stiff devices. Their flagship product, SOFT ECoG, is a subdural electrode that records from and stimulates the brain's surface, enhancing recording quality and minimizing MRI artifacts. Neurosoft's technology promotes long-term bio-integration, adapting to both static and dynamic mechanics of neural tissue, which can improve therapeutic outcomes for patients and expand the applications of neural interfaces in clinical settings.
The Content Engine
Debt Financing in 2021
The Content Engine is a technology platform designed to provide high-quality content at scale for organizations aiming to engage global audiences. By integrating machine learning with superior editorial practices, the platform streamlines the entire content creation process, including ideation, commissioning, production, approvals, and distribution. This approach allows organizations to efficiently publish engaging content daily across various channels, effectively combining technology and artistry to enhance communication. The Content Engine serves as both a workflow solution and a creative network, enabling clients to maximize their content output while maintaining high standards.
FluoSphera
Grant in 2021
FluoSphera is a company focused on the development of innovative drugs that minimize adverse side effects and reduce reliance on animal testing. By addressing the complexities of human physiological responses, FluoSphera aims to assist organizations in creating safer pharmaceuticals and protecting populations from harmful compounds. Their approach emphasizes efficiency in drug discovery, ultimately enhancing public health and safety.
HeroSupport
Grant in 2021
HeroSupport is a medical device manufacturing company based in Veyrier, Geneva, established in 2019. The company specializes in creating personalized solutions that transform imaging and treatment tables into medical immobilization devices designed to enhance patient comfort during clinical procedures. By providing tailored support, these devices allow patients to receive prone breast radiotherapy without the need to adapt to the standard table setup. This innovation not only improves patient comfort but also aims to enhance the effectiveness and cost efficiency of cancer treatment for healthcare providers.
Adiposs
Debt Financing in 2021
Adiposs SA is a clinical-stage life science company focused on developing innovative medical imaging products aimed at the early detection of cachexia, a serious condition characterized by severe body wasting. The company has created a first-in-class CT contrast product that allows for the detection of body wasting prior to noticeable weight loss, potentially up to a year earlier. This advancement enables healthcare providers to identify cancer at an earlier stage, ultimately improving patient outcomes and enhancing their quality of life. By facilitating timely intervention, Adiposs aims to provide patients with a better chance of survival against cancer and other chronic illnesses.
ORamaVR
Funding Round in 2020
ORamaVR is focused on transforming medical training through immersive virtual reality (VR) solutions. The company offers an IT platform, MAGES-SDK, that enables medical organizations to create high-fidelity VR simulations at a fraction of the cost and time compared to traditional methods. These simulations are utilized by hospitals, medical schools, and training centers to educate and evaluate medical professionals. The effectiveness of this platform is supported by nine clinical trials and over fifty scientific publications. ORamaVR has gained recognition from numerous prestigious institutions worldwide, including universities and healthcare organizations in the United States and Europe. The company has received several international awards for its societal impact and has established partnerships with notable organizations such as Airbus and Microsoft. Additionally, ORamaVR has secured venture capital funding from various strategic investors, including HTC Vive, further solidifying its position in the medical VR landscape.
Ovomind
Pre Seed Round in 2020
Ovomind is focused on transforming the gaming experience by integrating emotional interaction through innovative technology. The company has developed smart emotion computing wristbands that utilize sensors to detect players' emotional states from biosignals. This data is processed in real-time via a cloud-based algorithm, allowing game developers to adapt gameplay and streaming experiences based on the user's emotions. By centering on the human experience, Ovomind aims to create a new generation of user experience that enhances engagement and interactivity in video games. This approach seeks to redefine how players connect with games and with each other, fostering a more immersive and emotionally resonant gaming environment.
Commochain
Pre Seed Round in 2019
CommoChain SA is a Swiss company founded in 2018 that specializes in developing a fintech platform for the commodity trading sector. The platform utilizes blockchain and smart contract technology to enhance the security of financial transactions, making them more streamlined and efficient. CommoChain focuses on simplifying the back-office operations for exporters and importers of commodities and raw materials. By providing a secure and accelerated method for executing physical transactions, the company aims to improve operational efficiency for businesses engaged in international trade.
MagicTomato
Venture Round in 2019
MagicTomato operates an online grocery marketplace that focuses on providing locally made and sourced products. Founded in September 2016 in the Geneva area, the company aims to encourage consumers to adopt healthier grocery shopping habits by offering a selection of over 800 non-industrial and GMO-free items. Their product range includes fresh fruits, vegetables, meats, fish, dairy, organic flours, and various beverages, all sourced from a network of 30 local artisans. MagicTomato emphasizes sustainability through a decentralized business model, aiming to eliminate food waste and packaging while ensuring ultimate freshness. They offer same-day delivery, making it convenient for consumers to access high-quality products from independent craftsmen in their region. The company is already at breakeven, reflecting its successful implementation of this innovative grocery approach.
Quantum Integrity
Seed Round in 2018
Quantum Integrity SA, founded in 2017 and based in Geneva, Switzerland, specializes in software that analyzes images on a pixel-by-pixel basis to identify forgeries and manipulations. The company's technology examines forensic data from digital images, providing accurate detection of alterations irrespective of the methods or software used to create them. In addition to its focus on forgery detection, Quantum Integrity also enhances cyber communications by ensuring the integrity of digital media and safeguarding against potential manipulations.
Tokenestate.io
Seed Round in 2018
Tokenestate SA is a Swiss-based company that provides a security token issuance and management platform designed for investments in private companies and real estate. Founded in 2017 and located in Geneva, the platform leverages blockchain and digital signature technologies to facilitate fundraising, manage the buying and selling of shares, and conduct KYC and anti-money laundering checks. Additionally, Tokenestate offers Tokenization as a Service (TaaS) for real estate funds, enabling a marketplace for tokenized assets. The company's services streamline the management of securities and enhance the investor experience in the evolving landscape of digital finance.
Kejako
Seed Round in 2018
Kejako SA is a Swiss company specializing in the research and development of medical devices for the ophthalmic surgery sector, specifically targeting presbyopia. Founded in 2015 and headquartered in Plan-les-Ouates, Switzerland, Kejako aims to provide a non-invasive solution for patients experiencing a decline in visual accommodation due to age-related changes. The company employs a unique approach that combines simulation with minimally invasive treatments, utilizing a full eye 3D parametric model alongside multi-physics numerical modeling to assess the eye's optical and mechanical behavior. This innovation enables patients to better plan and control their customized procedures, ultimately enhancing their quality of life as they manage the effects of presbyopia.
CleverDist
Funding Round in 2017
CleverDist specializes in the design and development of industrial control systems, particularly for applications at CERN. The company offers a range of services related to supervisory control and data acquisition systems, focusing on the integration of control and automation technologies across various industries. Their offerings include conceptual design and prototyping, solution architecture, system integration, and supervisory systems. Additionally, CleverDist provides training and staffing services, aiming to enhance technology transfer and operational efficiency for businesses in need of advanced control system solutions.
Alohi
Seed Round in 2017
Alohi is a Swiss-based company that offers a cloud-based communication platform designed for entrepreneurs, small businesses, and individual consumers. Founded in 2015, Alohi provides services that include local phone numbers in various countries, along with features such as greeting messages, call forwarding, voicemail, fax, and announcements. The company focuses on two main platforms: one for self-service communications and another for legally binding electronic signatures. Its product lineup includes Sign.Plus, Fax.Plus, and Scan.Plus, which facilitate the electronic signing and verification of documents, as well as secure online fax services. This enables users to send and sign confidential documents safely, enhancing communication and agreement processes for both individuals and businesses.
MagicTomato
Seed Round in 2017
MagicTomato operates an online grocery marketplace that focuses on providing locally made and sourced products. Founded in September 2016 in the Geneva area, the company aims to encourage consumers to adopt healthier grocery shopping habits by offering a selection of over 800 non-industrial and GMO-free items. Their product range includes fresh fruits, vegetables, meats, fish, dairy, organic flours, and various beverages, all sourced from a network of 30 local artisans. MagicTomato emphasizes sustainability through a decentralized business model, aiming to eliminate food waste and packaging while ensuring ultimate freshness. They offer same-day delivery, making it convenient for consumers to access high-quality products from independent craftsmen in their region. The company is already at breakeven, reflecting its successful implementation of this innovative grocery approach.
Quantreex
Pre Seed Round in 2017
Quantreex is a web-based trading platform founded in 2016 and based in Geneva, Switzerland. The platform allows users to create automated trading strategies quickly and efficiently, leveraging machine learning and artificial intelligence. It enables users to monitor and backtest financial strategies across various instruments and markets, ensuring that strategies are verified before going live. By simplifying the process of developing and executing trading strategies, Quantreex aims to help users capitalize on market opportunities effectively.
Gmelius
Pre Seed Round in 2017
Gmelius Ltd is a Swiss company founded in 2016 that specializes in developing a software extension designed to enhance workflow automation and team collaboration within Google Workspace. Its platform allows users to manage emails, track projects, and automate various tasks such as scheduling campaigns and setting follow-up reminders, all without the need for migrating data to external applications. Gmelius offers features like shared inboxes, Kanban boards, email templates, and integration with other tools like Slack and Trello, facilitating seamless communication and project management. The platform aims to de-silo company data and enhance productivity by enabling real-time collaboration directly from users' email inboxes. Gmelius has attracted over 10,000 paid customers, including notable companies like Netflix and JustWorks.
ProtonVPN
Seed Round in 2017
ProtonVPN is Swiss-based VPN service, created by the same team of CERN scientists who created ProtonMail. ProtonVPN makes it possible to access the Internet without censorship and surveillance.
TwentyGreen
Seed Round in 2016
TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements designed for sustainable animal farming. Founded in 2015 and based in Root, Switzerland, the company has developed a triple active probiotic that addresses key challenges in intensive animal farming, such as improving digestion, enhancing responses to plant-based feeds, and promoting better feed conversion ratios. This innovative product, rooted in research on intestinal health from the École Polytechnique Fédérale de Lausanne (EPFL), aims to optimize gut microbiota, which is vital for food metabolism and immune defense. By offering significant benefits, such as reduced disease incidence and lower ecological impact, TwentyGreen seeks to capture a 10% share of the rapidly growing global animal feed probiotic market, valued at over $4 billion annually. To achieve this, the company engages in extensive research and development in collaboration with academic partners, ensuring compliance with regulatory standards for both human food and animal feed.
OrbiWise
Angel Round in 2016
OrbiWise is a Swiss company specializing in advanced technologies for the Internet of Things (IoT) industry, with a focus on developing a carrier-grade network server known as OrbiWAN, which is built on LoRa technology. This server enhances the performance of IoT services by providing real-time device messaging and targeted device group profiling, capable of supporting both single and multiple gateway access points across various environments, such as smart cities, rural areas, and industrial settings. OrbiWise's solutions aim to improve efficiency in agriculture and manufacturing, facilitate city parking, and enhance employee health and security. The company's team possesses a strong engineering background, with expertise in areas such as cloud and embedded software, communication systems, and RF/HW design. OrbiWise is committed to customer success and values honesty and innovation in its operations.
Prodibi
Seed Round in 2016
Prodibi is a professional image platform that enhances the online display of images to boost brand ROI, improve user engagement, and streamline the work of developers. Launched in 2011 and based in Geneva, Switzerland, the platform addresses common challenges in image quality, performance, color management, pixel density, responsiveness, and SEO, which can be costly and time-consuming to resolve. For example, tasks like cropping images can take significant time for graphic designers. Prodibi simplifies this process by allowing users to replace online images with a single click, ensuring an exceptional visual experience that aligns with brand prestige. The subscription-based service enables photographers, professional artists, and web publishers to showcase their work effectively on both web and mobile platforms without sacrificing speed or quality.
IPStock
Seed Round in 2016
The team of IPDM have worked in the Global Stock Image market for over 5 years. They has successfully created the world’s #1 ranked portfolio of vector images Macrovector, world’s most popular cloud service for photographers and artists IPSTOCK.COM, and a premium marketplace for vector illustrations Vectorplace.com. The new IPStock solution is a blockchain ecosystem designed for all marketplaces, content creators and consumers, content registry on blockchain and license management through smart-contracts.
Expedismart
Seed Round in 2016
Expedismart is a courier service comparison platform based in Switzerland that facilitates the sending of mail and parcels both domestically and internationally. The company enables customers to compare various courier options, allowing them to choose the most suitable service based on quality, pricing, and preferred delivery times. By offering an online booking system, Expedismart aims to streamline the shipping process, ensuring that customers can efficiently manage their parcel deliveries while saving on costs.
Ifluenz
Seed Round in 2016
Ifluenz is an Instagram influencer marketing platform designed to connect advertisers with influential Instagram users. The platform prioritizes influencers in its campaign planning, ensuring that they select brands and products that resonate with their audience. This approach fosters authentic engagement and activity surrounding the promoted content. Ifluenz employs advanced algorithms to review, sort, and classify influencers based on various criteria, enabling effective matching with campaigns created by brands. This functionality assists users in optimizing their product placement and enhancing brand visibility through targeted influencer collaborations.
Silver Wave Medical
Seed Round in 2016
Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries. Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.
Goodwall
Angel Round in 2015
Goodwall is a Swiss-based online platform, established in 2014, that connects students and young professionals. It enables users to create profiles displaying their achievements, skills, and ideas, facilitating interactions with universities and employers. The platform offers access to a vast database of job and internship opportunities, scholarships, and volunteer events, tailored to the needs of Gen Z and millennials.
Multiwave Technologies
Seed Round in 2015
Multiwave Imaging is a leading company specializing in the design of metamaterial antennas for Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) systems. Established in March 2015 and headquartered in Geneva, Switzerland, with a research and development facility in France, Multiwave focuses on developing innovative medical imaging devices. The company aims to enhance imaging quality in MRI, ultimately aiding in the treatment of neurological conditions. In addition to its core imaging technologies, Multiwave employs advanced quantitative portfolio analysis and sensor technologies to support retailers in their purchasing strategies, thereby maximizing profits. Through these initiatives, Multiwave Imaging seeks to advance the field of medical imaging while addressing critical healthcare needs.
Planet Intus
Seed Round in 2015
Planet Intus SA specializes in the design and development of indoor geolocation software, providing infrastructure that supports both active and passive geolocation services. Founded in 2014 and headquartered in Carouge, Switzerland, the company offers a range of applications for end users, including indoor guidance, safety services, and comfort services. Its software aims to enhance user experiences in various sectors such as retail, leisure, healthcare, and security. Additionally, Planet Intus delivers analytics and insights to help professionals improve marketing strategies and operational efficiency. The team consists of skilled engineers and technicians with expertise in Geographic Information Systems, indoor positioning technologies, and mobile app development, combining French telecommunication know-how with Swiss quality standards to deliver innovative solutions.
InvestGlass
Seed Round in 2015
InvestGlass operates a web-based platform that provides a range of tools for investors and financial institutions. Founded in 2013 and based in Carouge, Switzerland, the platform includes features such as Strategy Tutor, which assists investors in managing their investment strategies, alongside access to global market data, news, forecasts, and corporate announcements. In addition, InvestGlass offers an Educational Portal filled with strategies, articles, tools, and videos aimed at enhancing market understanding. The platform also includes solutions for digital onboarding, customer relationship management, and portfolio management, all designed to streamline operations and improve service delivery. By leveraging artificial intelligence, InvestGlass enables its clients to focus more on providing investment advice while handling compliance and operational tasks efficiently.
Proton Mail
Venture Round in 2015
Proton Mail is a free and secure email service that is powered by community, not surveillance capitalism. Its free plan is supported by paid subscriptions that offer extra features and storage. With Easy Switch, you can quickly migrate from any email provider to Proton Mail. It helps to import emails, labels, contacts, and calendars to Proton Mail and set up automatic forwarding to receive future emails in the new encrypted inbox.
ProtonMail Customer Care
Seed Round in 2015
Protonmail has revolutionized the email industry by providing secure and private email services, ensuring the privacy of its users. The customer support team of Protonmail plays a crucial role in maintaining the trust of the users by providing instant resolutions to their queries. The users can contact the Protonmail support team via email, chat, or the Protonmail Customer Care Number to resolve any issue related to Protonmail. With Protonmail, users can communicate conveniently and securely, leaving no room for data breaches.
Telexoo
Seed Round in 2014
Telexoo is a financial service provider based in Geneva, Switzerland, specializing in currency exchange. The company offers an online platform that allows users to create free accounts for seamless currency transfers at competitive rates. Users can initiate exchanges directly from their bank accounts, with transactions processed in real-time at the interbank rate. Telexoo distinguishes itself by providing personalized service through accessible exchange specialists, eliminating the need for a call center or ticketing system. This approach fosters a more direct and friendly user experience, akin to reaching out to a personal contact.
Aptissen
Seed Round in 2014
Aptissen SA, established in 2013 and headquartered in Plan-les-Ouates, Switzerland, specializes in the development, distribution, and commercialization of biopolymer-based medical devices and food supplements for joint health. The company's flagship product, Synolis VA, is a hyaluronic acid and sorbitol-based injectable solution that provides rapid mobility recovery and long-lasting pain relief for osteoarthritis patients. Aptissen's products are distributed through an extensive international network, reaching over 50 countries worldwide, and are supported by certifications including CE, ISO13485, MDSAP, and GMP compliance. The company operates through a 100% subcontracted model, with three supply sources located in Europe, and maintains subsidiaries in Italy, Poland, and France, along with two license partners.
nyce
Seed Round in 2014
nyce is a disruptive online Art Gallery collaborating with pioneering Artists producing their debut Art sculptures while exploring new territories.
CleverDist
Seed Round in 2014
CleverDist specializes in the design and development of industrial control systems, particularly for applications at CERN. The company offers a range of services related to supervisory control and data acquisition systems, focusing on the integration of control and automation technologies across various industries. Their offerings include conceptual design and prototyping, solution architecture, system integration, and supervisory systems. Additionally, CleverDist provides training and staffing services, aiming to enhance technology transfer and operational efficiency for businesses in need of advanced control system solutions.
Faveeo
Seed Round in 2013
Faveeo SA is a company based in Geneva, Switzerland, that provides collaborative intelligence solutions focused on web and social media management. Founded in 2012, Faveeo offers a suite of integrated tools designed to assist large organizations in handling both external and internal data streams. Its platform features a filtering and refining engine that identifies key concepts and sources relevant to various topics, industries, or brands. Additionally, Faveeo provides tools for content curation and analysis, as well as collaboration and publishing capabilities, which enhance organizations' access to essential insights. The company's solutions are utilized in media monitoring, competitive intelligence analysis, market research, social media engagement, and content marketing. Faveeo's services cater to a diverse range of clients, including research centers, non-governmental organizations, and international groups, aiming to streamline their information validation and enhance their strategic decision-making processes.
ProtonMail Customer Care
Grant in 2013
Protonmail has revolutionized the email industry by providing secure and private email services, ensuring the privacy of its users. The customer support team of Protonmail plays a crucial role in maintaining the trust of the users by providing instant resolutions to their queries. The users can contact the Protonmail support team via email, chat, or the Protonmail Customer Care Number to resolve any issue related to Protonmail. With Protonmail, users can communicate conveniently and securely, leaving no room for data breaches.
V-Labs
Seed Round in 2013
V-Labs specializes in augmented reality technology tailored for excavation operations. The company has developed a system that allows users to visualize complex geospatial data directly at the worksite with centimeter-level accuracy. This technology includes a local positioning system that aids operators and contractors in minimizing damage to underground infrastructure while enhancing the efficiency of excavation processes. By integrating augmented reality into excavation tasks, V-Labs aims to improve safety and streamline workflows in the construction industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.